Regulations, Pricing, and Power Players: Market-Moving Healthcare Trends to Watch in Q4

The healthcare and life science industries are continuing to shift as we head into 2024, with strong movements in the regulatory environment and M&A landscape. Drugmakers, payers, and providers are changing strategies to more quickly and cost-effectively bring treatments to market, compete with emerging players, acquire medical technology, implement generative AI, and grow market share in an increasingly crowded and regulated industry.

Watch this exclusive session with Geoff Meacham, Senior Pharmaceutical & Biotech Analyst of BofA Securities where he answers:

• Which key trends will shape the healthcare and life sciences markets in 2024 and beyond
• How M&A strategies are shifting for incumbent leaders and emerging players across biopharma, medtech and healthcare
• What changes in the regulatory environment mean for major players in the healthcare industry